VHL and von Hippel-Lindau disease: To isolate and culture primary HB-tumors derived from VHL patient surgeries [16,17] open a key opportunity to characterize VHL-derived HB cells and to test drugs with therapeutic aims, thus reducing the need of recurrent surgeries in VHL patients.